Accessibility Menu
Savara Stock Quote

Savara (NASDAQ: SVRA)

$4.23
(2.9%)
+0.12
Price as of October 21, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$4.23
Daily Change
(2.9%) +$0.12
Day's Range
$3.99 - $4.25
Previous Close
$4.23
Open
$4.09
Beta
0.83
Volume
1,281,818
Average Volume
1,391,812
Market Cap
710.4M
Market Cap / Employee
$4.11M
52wk Range
$1.89 - $4.3
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
-$0.51
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Savara Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
SVRA+18.49%+264.66%+29.53%-53%
S&P+14.84%+96.04%+14.41%+182%

Savara Company Info

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Austin, TX.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$0.00M0.0%
Gross Profit-$0.07M-7.2%
Market Cap$394.07M-29.2%
Market Cap / Employee$6.68M0.0%
Employees5959.5%
Net Income-$30.40M-36.7%
EBITDA-$31.37M-35.7%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$17.44M-26.9%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$29.65M12.0%
Short Term Debt$0.09M-40.8%

Ratios

Q2 2025YOY Change
Return On Assets-72.72%-14.7%
Return On Invested Capital-38.32%2.8%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$26.28M-16.7%
Operating Free Cash Flow-$26.26M-16.7%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book3.632.632.792.66-41.72%
Price to Tangible Book Value3.852.792.962.87-42.68%
Enterprise Value to EBITDA-26.84-15.82-16.07-12.01-56.67%
Return on Equity-48.0%-61.5%-75.8%-99.3%24.94%
Total Debt$26.71M$26.82M$29.65M$29.74M11.66%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.